Carol G. Gallagher Net Worth & Insider Trades
Carol G. Gallagher - Director, Atara Biotherapeutics, Inc
What is Carol G. Gallagher's Net Worth?
The current estimated net worth of Atara Biotherapeutics, Inc's Director, Carol G. Gallagher, is estimated to be about $4.53M . Carol G. Gallagher owns about 111,192 units of Atara Biotherapeutics, Inc common stock. In the last 4 years at Atara Biotherapeutics, Inc, Carol G. Gallagher has sold an estimated value of $1.56M worth.
What is Carol G. Gallagher's Past Insider Trading?
Carol G. Gallagher's largest purchase order was 51,656 units , worth over $199.99K on October 23, 2014. Carol G. Gallagher's largest sale order was 17,622 units , worth over $746.09K on August 24, 2015. In total, Carol G. Gallagher has made about 18 transactions over 4 years of their time at Atara Biotherapeutics, Inc. Carol G. Gallagher usually trades in February and August, with the busiest year in 2017. The most recent transaction was a sale order of 273 units , worth over $12.57K on May 16, 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Giltner Carol Gallagher
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Carol G. Gallagher's' Mailing Address?
- Mailing address is C/o Atara Biotherapeutics, Inc. 3260 Bayshore Boulevard Brisbane CA 94005 CA
Atara Biotherapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Pascal Touchon, D.V.M. | 2020 | $654,857 | $422,500 | $2,235,600 | $1,959,208 | $13,662 | $5,285,827 |
| Pascal Touchon, D.V.M. | 2019 | $319,327 | $334,791 | $2,861,712 | $3,049,718 | $71,760 | $6,637,307 |
| Jakob Dupont, M.D. | 2020 | $319,231 | $143,346 | $443,075 | $1,757,296 | $133,297 | $2,796,245 |
| Utpal Koppikar | 2020 | $460,947 | $187,032 | $885,431 | $597,073 | $7,470 | $2,137,953 |
| Utpal Koppikar | 2019 | $439,875 | $155,606 | $1,034,714 | $909,080 | $895 | $2,540,170 |
| Utpal Koppikar | 2018 | $240,289 | $189,771 | $1,903,500 | $1,886,325 | $398 | $4,220,282 |
| Joseph Newell | 2020 | $466,055 | $203,435 | $1,033,965 | $566,713 | $895 | $2,251,063 |
| Joseph Newell | 2019 | $390,000 | $155,208 | $1,240,675 | $932,390 | $895 | $2,719,167 |
| Joseph Newell | 2018 | $365,000 | $155,490 | $895,000 | $1,060,710 | $16,092 | $2,492,292 |
| Kristin Yarema, Ph.D. | 2020 | $368,308 | $147,995 | $668,250 | $1,067,484 | $184,370 | $2,436,407 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1604464/000156459021020128/atra-def14a_20210608.htm
What are Atara Biotherapeutics, Inc's Past Insider Trades?
Atara Biotherapeutics, Inc's most recent insider trade came on August 18, 2023 by Eric J Hyllengren who sold 8,186 units worth $13.53K . In the last 9 years, insiders at Atara Biotherapeutics, Inc have sold an estimated value of $73.66M and bought an estimated value of $10.47M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Isaac E Ciechanover, Chief Executive Officer, Christopher Haqq, EVP, and Joe Newell, Chief Operations Officer .
Atara Biotherapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||